Radiogenomics in Lymphoma and Multiple Myeloma: A Systematic Review of Current Evidence and Future Directions
Journal of Clinical Medicine · 23.05.2026 · 15 (11) · 4048
DOI: 10.3390/jcm15114048 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 23.05.2026. Verfasst von Valentina Formica und 11 weiteren Autor:innen. Beteiligte Einrichtung: Academic Radiology, Department of Surgical, Medical, Molecular Pathology and Emergency Medicine, University of Pisa, 56126 Pisa, Italy. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'università e della ricerca, European Union—NextGenerationEU.
Abstract (Originalsprache)
Background/Objectives: Radiogenomics integrates quantitative imaging features with genomic and molecular data to better characterize tumor biology and support precision oncology. While extensively investigated in solid tumors, its application to hematologic malignancies remains relatively unexplored despite the widespread use of advanced imaging in lymphoma and multiple myeloma.
Methods
A systematic review was conducted following PRISMA 2020 guidelines. PubMed, Scopus, and Web of Science were searched up to December 2025 for studies investigating radiogenomic associations in hematologic malignancies. Study quality was assessed using PROBAST and METRICS. Two reviewers independently screened all records and performed data extraction through consensus.
Results
Twelve studies were included, covering multiple myeloma and various lymphoma subtypes (aggressive B-cell lymphoma, classical Hodgkin lymphoma, and primary CNS lymphoma). Imaging modalities included PET/CT, MRI and CT. Across studies, radiomic and imaging-derived features were associated with cytogenetic abnormalities, gene expression profiles, and circulating tumor DNA metrics. In multiple myeloma, MRI and CT-based radiomics showed promising ability to predict high-risk cytogenetic abnormalities. In lymphoma, PET-derived volumetric and dissemination features correlated with molecular risk profiles and tumor microenvironment characteristics. Several studies demonstrated improved prognostic performance when imaging features were combined with genomic or clinical variables.
Conclusions
Radiogenomic approaches in hematologic malignancies show promising potential for non-invasive risk stratification and improved prognostic assessment. However, current evidence remains limited by small cohorts, heterogeneous methodologies, and a lack of external validation. Prospective multicenter studies and standardized imaging–genomic pipelines will be essential to enable clinical translation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Academic Radiology, Department of Surgical, Medical, Molecular Pathology and Emergency Medicine, University of Pisa, 56126 Pisa, Italy.
- Nuclear Medicine Unit, Department of Translational Research and of New Surgical and Medical Technology, University of Pisa, 56126 Pisa, Italy.
- Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.
- Academic Radiology, Department of Translational Research and of New Surgical and Medical Technology, University of Pisa, 56126 Pisa, Italy.
- Department of Life Sciences, Health and Health Professions, Link Campus University, 00165 Rome, Italy.
- Italian Society of Medical and Interventional Radiology, SIRM Foundation, 20122 Milan, Italy.
ORCID-Profile: Gayane Aghakhanyan, Valentina Baccolini, Francesca Pia Caputo, Roberto Francischello, Giuseppe Migliara, Emanuele Neri, Dania Cioni
Förderung
- Ministero dell'università e della ricerca
- European Union—NextGenerationEU
Zitieren
APA
Formica, V., Aghakhanyan, G., Baccolini, V., Caputo, F. P., Fanni, S. C., Francischello, R., Migliara, G., Volterrani, D., Lencioni, R. A., Villari, P., Neri, E., & Cioni, D. (2026). Radiogenomics in Lymphoma and Multiple Myeloma: A Systematic Review of Current Evidence and Future Directions. Journal of Clinical Medicine, 15(11), 4048. https://doi.org/10.3390/jcm15114048
Vancouver
Formica V, Aghakhanyan G, Baccolini V, Caputo FP, Fanni SC, Francischello R, et al. Radiogenomics in Lymphoma and Multiple Myeloma: A Systematic Review of Current Evidence and Future Directions. Journal of Clinical Medicine. 2026;15(11):4048. doi:10.3390/jcm15114048
BibTeX
@article{Formica2026,
author = {Formica, Valentina and Aghakhanyan, Gayane and Baccolini, Valentina and Caputo, Francesca Pia and Fanni, Salvatore Claudio and Francischello, Roberto and Migliara, Giuseppe and Volterrani, Duccio and Lencioni, Riccardo Antonio and Villari, Paolo and Neri, Emanuele and Cioni, Dania},
title = {Radiogenomics in Lymphoma and Multiple Myeloma: A Systematic Review of Current Evidence and Future Directions},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {11},
pages = {4048},
doi = {10.3390/jcm15114048}
}
EUVIMED